Navigation Links
AIDS Vaccines: Where Do We Go From Here?
Date:7/28/2008

The International AIDS Vaccine Initiative (IAVI) and Key Thought Leaders Explore Critical Next Steps for AIDS Vaccine Research at the 17th International AIDS Conference in Mexico City

NEW YORK, July 28 /PRNewswire-USNewswire/ -- The following was released today by the International AIDS Vaccine Initiative:

WHAT:

Today, AIDS vaccine research is at a pivotal moment. Just ten months ago, the second AIDS vaccine candidate to reach late-stage testing failed. In the wake of this disappointment, some skeptics have argued that an AIDS vaccine may not be possible and that resources dedicated to its development should be directed instead towards treating HIV-infected individuals. Now is the time to take a hard look at the toughest questions currently facing AIDS vaccine researchers. How should the finite resources for AIDS vaccine research be prioritized? How can the toughest scientific questions facing AIDS vaccine researchers be tackled? What criteria should be used to decide which vaccine candidates merit further testing, and which should be dropped? How do you continue to sustain much-needed support for a preventive vaccine that may take decades to develop?

In its biennial AIDS Vaccine Blueprint: A Challenge to the Field, a Roadmap for Progress, IAVI will put forth a series of concrete recommendations and milestones that will guide research to answer the critical scientific questions that have hampered AIDS vaccine development to date.

WHY:

The AIDS pandemic is one of the greatest global health crises of our time. In the 25 years since HIV was first identified as the cause of AIDS, an estimated 25 million people have died of the disease and 33 million more are currently living with HIV. Almost 7,000 people become newly infected with HIV everyday, and for every two people who start antiretroviral therapy, another five become newly infected with HIV. While a preventive vaccine is the best long-term solution to the pandemic, much still remains to be done to discover and make a vaccine accessible globally.

WHO:

Seth Berkley, MD, CEO and President, International AIDS Vaccine Initiative (IAVI)

Peter Piot, MD, Executive Director, UNAIDS and Under Secretary-General, United Nations

Alan Bernstein, MD, Executive Director, Global HIV Vaccine Enterprise

Omu Anzala, MD, Associate Professor, University of Nairobi School of Medicine

WHERE:

Media Centre, Room 2

WHEN:

Tuesday, August 5 (9:00AM to 9:45AM)

CONTACT: Hester Kuipers

hkuipers@iavi.org

+31 20 5210343 / +31 64898130

Rachel Steinhardt

rsteinhardt@iavi.org

212-847-1045


'/>"/>
SOURCE International AIDS Vaccine Initiative
Copyright©2008 PR Newswire.
All rights reserved

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... Russ ... announced the first national #QuackGivesBack campaign which supported local breast cancer organizations during ... franchise-wide Quack Gives Back initiative, and we’re very pleased with the ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... Suite 10.2 version gives development continuity to its innovative Unified Instance Manager ... management capacity. In addition, this new version optimizes the unattended auto-dialing system ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... STAT courier ... to be a convenient service for Texas, they are expanding their presence in Dallas. ... a hiring spree that will bring new jobs to the Dallas and Forth Worth ...
Breaking Medicine News(10 mins):